Extension study of sotatercept in people with pulmonary hypertension (MK-7962-023)

Trial Identifier:	7962-023
Sponsor:	MSD
Start Date:	April 2025
Primary Completion Date:	March 2029
Study Completion Date:	March 2029
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.